BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8113525)

  • 41. Prevalence of oral mucosal lesions among smokeless tobacco usage: A cross-sectional study.
    Hallikeri K; Naikmasur V; Guttal K; Shodan M; Chennappa NK
    Indian J Cancer; 2018; 55(4):404-409. PubMed ID: 30829279
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Perceived smokeless tobacco addiction among adolescents.
    Riley WT; Barenie JT; Woodard CE; Mabe PA
    Health Psychol; 1996 Jul; 15(4):289-92. PubMed ID: 8818675
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Smokeless tobacco use in the United States: the adult use of tobacco surveys.
    Novotny TE; Pierce JP; Fiore MC; Davis RM
    NCI Monogr; 1989; (8):25-8. PubMed ID: 2785647
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral mucosal findings related to tobacco use and alcohol consumption: a study on Swiss army recruits involving self-reported and clinical data.
    Morger R; Ramseier CA; Rees TD; Bürgin WB; Bornstein MM
    Oral Health Prev Dent; 2010; 8(2):143-51. PubMed ID: 20589248
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of smokeless tobacco by young adult females.
    Boyle RG; Gerend MA; Peterson CB; Hatsukami DK
    J Subst Abuse; 1998; 10(1):19-25. PubMed ID: 9720003
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The prevalence of smokeless tobacco and cigarette use among sixth, seventh and eighth grade students: a longitudinal investigation.
    Abernathy TJ; Bertrand LD
    Can J Public Health; 1992; 83(1):15-8. PubMed ID: 1571876
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of risk factors for oral leukoplakia in West Virginia.
    Fisher MA; Bouquot JE; Shelton BJ
    Community Dent Oral Epidemiol; 2005 Feb; 33(1):45-52. PubMed ID: 15642046
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Coaches' attitudes toward smokeless tobacco and intentions to intervene with athletes.
    Horn KA; Maniar SD; Dino GA; Gao X; Meckstroth RL
    J Sch Health; 2000 Mar; 70(3):89-94. PubMed ID: 10763476
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Midproject findings from a study of the National Collegiate Athletic Association's policy on smokeless tobacco use.
    Chakravorty B; Ahmed A; Buchanan RJ
    Subst Use Misuse; 2000 Aug; 35(10):1431-41. PubMed ID: 10921433
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of nass use and smoking on the risk of oral leukoplakia.
    Zaridze DG; Blettner M; Matiakin EG; Poljakov BP; Stich HF; Rosin MP; Hoffmann D; Brunnemann KD
    Cancer Detect Prev; 1986; 9(5-6):435-40. PubMed ID: 3779705
    [TBL] [Abstract][Full Text] [Related]  

  • 51. More to it than smokeless.
    Ephros H; Blitz M
    J Am Dent Assoc; 1999 Nov; 130(11):1558. PubMed ID: 10573921
    [No Abstract]   [Full Text] [Related]  

  • 52. A spit tobacco cessation intervention for college athletes: three-month results.
    Masouredis CM; Hilton JF; Grady D; Gee L; Chesney M; Hengl L; Ernster V; Walsh MM
    Adv Dent Res; 1997 Sep; 11(3):354-9. PubMed ID: 9524436
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Smokeless tobacco: questions of clinical significance.
    Moore GF; Lydiatt D; Massey J; Yonkers AJ
    Nebr Med J; 1986 Dec; 71(12):427-31. PubMed ID: 3796761
    [No Abstract]   [Full Text] [Related]  

  • 54. Tobacco use and oral disease.
    Winn DM
    J Dent Educ; 2001 Apr; 65(4):306-12. PubMed ID: 11336115
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Smokeless tobacco cessation intervention for college athletes: results after 1 year.
    Walsh MM; Hilton JF; Masouredis CM; Gee L; Chesney MA; Ernster VL
    Am J Public Health; 1999 Feb; 89(2):228-34. PubMed ID: 9949754
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative patterns of smokeless tobacco usage among major league baseball personnel.
    Wisniewski JF; Bartolucci AA
    J Oral Pathol Med; 1989 Jul; 18(6):322-6. PubMed ID: 2810130
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Smokeless tobacco use among big ten wrestlers and selected associated factors.
    Hannam SE
    Subst Use Misuse; 1997 Feb; 32(3):369-76. PubMed ID: 9058481
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prostaglandin E2 and interleukin-1 levels in smokeless tobacco-induced oral mucosal lesions.
    Johnson GK; Poore TK; Squier CA; Wertz PW; Reinhardt RA; Vincent SD
    J Periodontal Res; 1994 Nov; 29(6):430-8. PubMed ID: 7877079
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of social influences and tobacco availability on adolescent smokeless tobacco use.
    Boyle RG; Claxton AJ; Forster JL
    J Adolesc Health; 1997 Apr; 20(4):279-85. PubMed ID: 9098731
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Smokeless tobacco usage: a growing and menacing addiction among Hoosier children and young adults.
    Christen AG
    Indiana Med; 1996; 89(2):176-80. PubMed ID: 8867418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.